Tag: Frankfurt:ANU

XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange

CALGARY, Alberta, June 12, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that the Company has elected to voluntarily delist its common shares from the TSX Venture Exchange (“TSXV”). The Company will provide additional information on timing for the completion of the delisting of its common shares in a separate press release.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsFrankfurt:ANU

Kingworld Medicines Group (01110.HK) Signs MOU to Pursue Exclusive Distribution Rights for Two Lingnan Formula Products

Banqup Group Announces Strategic Simplification Plan and Launch of Process to Explore Strategic Alternatives

We Mean Business Coalition: New polling shows overwhelming global business support for clean electrification amid fossil fuel volatility

Tag: Frankfurt:ANU

XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us